Written by Klarity Editorial Team
Published: Jul 11, 2026

Last updated: July 11, 2026
If you have Cigna health insurance in Mississippi and are exploring ADHD treatment, understanding your pharmacy and behavioral health benefits before your first appointment can save significant time and money. Cigna operates in Mississippi through several commercial plan types, and its pharmacy benefits are administered through Express Scripts (ESI) — one of the nation’s largest pharmacy benefit managers. Whether a specific ADHD medication is covered, at what cost tier, and whether prior authorization is required will depend on your specific Cigna plan, formulary year, and ESI drug list.
This guide walks through Cigna’s Mississippi plan types, the Express Scripts ADHD formulary, prior authorization rules, Cigna’s PA criteria for stimulant medications, Mississippi’s mental health parity law, and how telehealth providers may fit into your coverage picture. Coverage details vary by plan — always verify your individual benefits before scheduling care.
Ready to explore ADHD treatment online? Klarity Health connects patients in Mississippi with licensed providers who can evaluate and treat ADHD where clinically appropriate. See if ADHD treatment may be right for you →
Cigna offers several commercial plan types in Mississippi. The plan type you have determines your network flexibility and how referrals work for mental health specialists, including psychiatrists and nurse practitioners who treat ADHD.
Your plan documents — available through your myCigna member portal or the Summary of Benefits and Coverage (SBC) — specify which network and formulary apply to your enrollment. Employer-sponsored self-funded plans may have customized formularies that differ from standard Cigna commercial formularies.
Cigna uses Express Scripts (ESI) as its pharmacy benefit manager for most commercial plans in Mississippi. ESI maintains a tiered National Preferred Formulary that determines how much members typically pay out-of-pocket for covered prescriptions. Stimulant medications — the most commonly prescribed first-line treatments for ADHD — are classified as Schedule II controlled substances under the federal Controlled Substances Act.
The following table reflects typical ESI commercial formulary tier placements for stimulant ADHD medications as of 2026. Your actual cost-sharing depends on your specific plan’s deductible, copay structure, and formulary year.
| Medication | Generic Name | Typical Tier | Notes |
|---|---|---|---|
| Adderall (generic) | Amphetamine salts IR | Tier 1 | Preferred generic; lowest typical copay; PA may apply for brand |
| Adderall XR (generic) | Amphetamine salts XR | Tier 1–2 | Generic preferred; brand requires step therapy under Cigna PA policy |
| Ritalin (generic) | Methylphenidate IR | Tier 1 | Widely available preferred generic |
| Concerta (generic) | Methylphenidate ER | Tier 1–2 | Extended-release; PA may apply for brand; generic preferred |
| Vyvanse (generic) | Lisdexamfetamine | Tier 1–2 | Generic lisdexamfetamine on formulary; brand requires PA and step therapy |
| Focalin XR (generic) | Dexmethylphenidate ER | Tier 1–2 | Preferred generic; brand requires step therapy documentation |
| Dexedrine (generic) | Dextroamphetamine SR | Tier 1–2 | Preferred generic for appropriate patients |
Formulary tiers and cost-sharing are subject to change. Members should verify current tier placement through the myCigna member portal, the ESI pharmacy help desk, or Klarity’s benefits verification process before filling a prescription.
Non-stimulant ADHD medications are an important alternative for patients who do not respond to stimulants, have cardiovascular contraindications, or prefer a non-controlled-substance option. Unlike stimulants, non-stimulants are not Schedule II controlled substances, which means different prescribing rules apply (see the EPCS section below).
| Medication | Generic Name | Typical Tier | Notes |
|---|---|---|---|
| Strattera (generic) | Atomoxetine | Tier 1–2 | First-choice non-stimulant; non-scheduled; generally low cost-sharing |
| Intuniv (generic) | Guanfacine ER | Tier 1 | Alpha-2 agonist; used for ADHD and impulsivity; non-scheduled |
| Kapvay (generic) | Clonidine ER | Tier 1 | Often used adjunctively; non-scheduled |
| Qelbree | Viloxazine ER | Tier 3–4 | Newer brand; prior authorization typically required; non-scheduled |
| Wellbutrin (generic) | Bupropion | Tier 1 | Off-label use for ADHD; non-scheduled; low cost; sometimes used when stimulants are contraindicated |
Cigna’s Coverage Policy IP0477 (effective May 15, 2026) requires prior authorization for all ADHD stimulant medications under employer plans. Cigna’s PA policy is structured around a “preferred product” step therapy framework, which means brand-name stimulants generally require documented trial and failure of the bioequivalent generic alternative before approval will be granted.
For an ADHD stimulant to be approved, the member must have a documented diagnosis of ADHD. Beyond the diagnosis requirement, brand-name stimulant coverage under Cigna typically requires one of the following:
All stimulant approvals are typically granted for a one-year period, after which re-authorization may be required.
If a PA is denied, Cigna members have the right to appeal. Mississippi state law and federal MHPAEA rules require that mental health PA criteria not be more stringent than those applied to comparable medical or surgical benefits. Providers may submit PA requests through the Cigna provider portal or via the Express Scripts pharmacy help desk. Members can reach Cigna member services at 1-800-244-6224 and Express Scripts at 1-800-835-3784.
All stimulant ADHD medications — including amphetamine salts (Adderall), methylphenidate (Ritalin/Concerta), lisdexamfetamine (Vyvanse), and dextroamphetamine — are classified as Schedule II controlled substances under the federal Controlled Substances Act. In Mississippi, Schedule II prescriptions are subject to Electronic Prescribing for Controlled Substances (EPCS) requirements under Miss. Code Ann. § 456.44.
This means your prescribing provider must use a DEA-compliant EPCS system to transmit stimulant ADHD prescriptions electronically to your pharmacy. Paper prescriptions for Schedule II medications are generally not accepted except in limited circumstances (such as technological failure, as permitted under applicable DEA rules).
Key EPCS facts for Cigna MS members seeking ADHD stimulants:
Mississippi law requires that insured health benefit plans provide mental health and substance use disorder benefits that are no more restrictive than benefits provided for comparable medical and surgical conditions. This requirement is codified in Miss. Code Ann. § 83-9-353 et seq. and is reinforced at the federal level by the Mental Health Parity and Addiction Equity Act (MHPAEA).
Under parity rules, Cigna may not apply more stringent prior authorization criteria, visit limits, or cost-sharing to ADHD treatment than it applies to comparable physical health conditions. If you believe your plan is imposing discriminatory limits on ADHD care, you may file a complaint with the Mississippi Department of Insurance (MS DOI) at 1-800-562-2957 or contact the U.S. Department of Labor (for employer-sponsored ERISA plans).
A significant portion of Cigna-administered plans in Mississippi are self-funded employer plans governed by the federal Employee Retirement Income Security Act (ERISA). Self-funded ERISA plans are generally exempt from Mississippi state insurance mandates, including Miss. Code Ann. § 83-9-353. Federal MHPAEA protections still apply to these plans, but state-specific parity enforcement mechanisms may not. If your Cigna plan is employer-sponsored, review your Summary Plan Description (SPD) or contact your HR department to determine whether your plan is fully insured (subject to Mississippi law) or self-funded (governed by ERISA).
Many Cigna plans in Mississippi may cover telehealth services for ADHD, including online psychiatric evaluations, ADHD assessments, and ongoing medication management. Telehealth coverage for behavioral health became a more standard benefit following the COVID-19 public health emergency, and Cigna has maintained telehealth parity for many plan types.
Key considerations for telehealth ADHD care with Cigna in Mississippi:
Klarity Health offers online ADHD treatment in Mississippi and works with many Cigna plans. Licensed providers on the Klarity platform can evaluate and, where appropriate, prescribe ADHD medications. Check if ADHD treatment may be right for you →
Cigna plans in Mississippi may cover ADHD treatment under mental health benefits. Coverage depends on your specific plan, network status, deductible, and prior authorization status. We recommend verifying your specific benefits through the myCigna member portal or Klarity’s benefits check before booking.
Many Cigna plans in Mississippi may cover ADHD medications — including stimulants and non-stimulants — under pharmacy benefits administered by Express Scripts (ESI). Generic stimulants are generally preferred. Brand-name stimulants typically require prior authorization and documented step therapy. Verify your pharmacy benefits with Cigna or ESI before filling a prescription.
Yes. Cigna’s Coverage Policy IP0477 (effective May 15, 2026) requires prior authorization for all ADHD stimulant medications under employer plans. Generics are preferred. Brand-name stimulants generally require documentation that the generic equivalent was tried and caused intolerance, or was inadequately effective. Approvals are typically valid for one year.
Copays for ADHD treatment with Cigna in Mississippi depend on your specific plan’s benefit structure, deductible status, and whether you are seeing an in-network provider. Review your Summary of Benefits or contact Cigna member services at 1-800-244-6224 to confirm your cost-sharing amounts.
Referral requirements depend on your plan type. Cigna HMO plans in Mississippi may require a referral from your PCP to see a mental health specialist for ADHD. Open Access Plus (OAP) PPO plans typically do not require referrals. Check your plan documents or contact Cigna to confirm.
Express Scripts covers a broad range of ADHD medications under Cigna commercial plans, including generic amphetamine salts, generic methylphenidate, generic lisdexamfetamine, atomoxetine (generic Strattera), guanfacine ER (generic Intuniv), and clonidine ER (generic Kapvay). Tier placement, PA requirements, and cost-sharing vary by plan. Use the ESI member portal or call 1-800-835-3784 to look up your specific plan’s formulary.
Many Cigna plans in Mississippi may cover telehealth services for ADHD, including online evaluations and medication management. Telehealth coverage varies by plan. Klarity Health offers online ADHD treatment in Mississippi and can help verify your telehealth benefits before your first visit.
Log in to your myCigna member portal, call the member services number on your insurance card (or 1-800-244-6224), or use Klarity’s benefits verification process. For pharmacy benefits, contact Express Scripts at 1-800-835-3784. Confirming your coverage before your first appointment helps avoid unexpected costs.
Klarity Health works with many insurance plans in Mississippi. Network participation may vary by individual provider and plan type. Use Klarity’s benefits verification process to confirm whether our providers may be in-network with your Cigna plan before scheduling.
Insurance coverage varies by plan, insurer, and state. The information on this page is intended as general guidance only and does not constitute a guarantee of benefits. Telehealth provider availability may vary by state. Stimulant prescribing via telehealth is subject to applicable DEA regulations and state law. Please verify your specific plan’s mental health and pharmacy coverage with your insurer or through Klarity’s benefits check before booking. For insurance complaints in Mississippi, contact the MS Department of Insurance at 1-800-562-2957 or visit www.mid.ms.gov.
Check if your Cigna plan may cover ADHD treatment in Mississippi →
Find the right provider for your needs — select your state to find expert care near you.